Position history for CITADEL ADVISORS LLC's holdings in DESIGN THERAPEUTICS INC
CITADEL ADVISORS LLC holds 231,513 shares of DSGN (DESIGN THERAPEUTICS INC), worth $2.5M as of 2026-Q1. The position was decreased (-49.7% shares). DSGN represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$2.5M
Current Shares
231,513
Total Value Change
+$1.4M
Total Shares Change
-73,117
Other major holders of DSGN: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.
Decreased |
| 231,513 |
-49.7% |
| $2.5M |
| 0.0% |
| $10.00 |
0 |
| 2025-Q4 | Decreased | 459,874 | -17.0% | $4.3M | 0.0% | $9.79 | 0 |
| 2025-Q3 | Decreased | 554,020 | -34.1% | $4.2M | 0.0% | $6.85 | 0 |
| 2025-Q2 | Decreased | 840,793 | -12.7% | $2.8M | 0.0% | $3.57 | 0 |
| 2025-Q1 | Increased | 963,460 | +0.5% | $3.7M | 0.0% | $4.21 | 27 |
| 2024-Q4 | Increased | 958,793 | +66.6% | $5.9M | 0.0% | $6.17 | 40 |
| 2024-Q3 | Increased | 575,550 | +88.9% | $3.1M | 0.0% | $5.33 | 41 |
| 2024-Q2 | Decreased | 304,630 | -65.2% | $1M | 0.0% | $3.35 | 0 |